TG THERAPEUTICS, INC. - 10-Q Filing
TG Therapeutics reports Q3 2026 financial results including revenue from product and license segments.
Tickers: $TGTX
TG Therapeutics reports Q3 2026 financial results including revenue from product and license segments.
Tickers: $TGTX